NO155053C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser.

Info

Publication number
NO155053C
NO155053C NO801290A NO801290A NO155053C NO 155053 C NO155053 C NO 155053C NO 801290 A NO801290 A NO 801290A NO 801290 A NO801290 A NO 801290A NO 155053 C NO155053 C NO 155053C
Authority
NO
Norway
Prior art keywords
spirobenzofuranon
compounds
preparation
therapeutically effective
analogue procedure
Prior art date
Application number
NO801290A
Other languages
English (en)
Other versions
NO801290L (no
NO155053B (no
Inventor
Hirosada Sugihara
Masazumi Watanabe
Mitsuru Kawada
Isuke Imada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5508279A external-priority patent/JPS55147271A/ja
Priority claimed from JP8055179A external-priority patent/JPS5931511B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO801290L publication Critical patent/NO801290L/no
Priority to NO811788A priority Critical patent/NO154839C/no
Priority to NO811787A priority patent/NO154838C/no
Publication of NO155053B publication Critical patent/NO155053B/no
Publication of NO155053C publication Critical patent/NO155053C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO801290A 1979-05-04 1980-05-02 Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser. NO155053C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO811788A NO154839C (no) 1979-05-04 1981-05-26 Analogifremgangsmaate for fremstilling av en 7-acetylspirobenzofuranonforbindelse med terapeutisk aktivitet.
NO811787A NO154838C (no) 1979-05-04 1981-05-26 Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5508279A JPS55147271A (en) 1979-05-04 1979-05-04 Spiro compound and its preparation
JP8055179A JPS5931511B2 (ja) 1979-06-25 1979-06-25 スピロ化合物およびその製造方法

Publications (3)

Publication Number Publication Date
NO801290L NO801290L (no) 1980-11-05
NO155053B NO155053B (no) 1986-10-27
NO155053C true NO155053C (no) 1987-02-04

Family

ID=26395929

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801290A NO155053C (no) 1979-05-04 1980-05-02 Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser.

Country Status (10)

Country Link
EP (3) EP0039091B1 (no)
AT (1) AT383122B (no)
AU (1) AU534940B2 (no)
CA (3) CA1150287A (no)
DE (1) DE3063660D1 (no)
DK (1) DK153551C (no)
ES (4) ES8104996A1 (no)
GR (1) GR66729B (no)
NO (1) NO155053C (no)
SU (1) SU1022658A3 (no)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149891C (da) * 1977-12-27 1987-06-15 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af spirobenzofuranon-forbindelser eller salte deraf med uorganiske eller organiske syrer eller alkalimetaller

Also Published As

Publication number Publication date
DE3063660D1 (en) 1983-07-14
ATA233880A (de) 1986-10-15
NO801290L (no) 1980-11-05
ES8205405A1 (es) 1982-06-01
EP0039091A1 (en) 1981-11-04
ES8203874A1 (es) 1982-04-01
ES491150A0 (es) 1981-05-16
EP0018830B1 (en) 1983-06-08
ES497669A0 (es) 1982-06-01
SU1022658A3 (ru) 1983-06-07
EP0018830A2 (en) 1980-11-12
AT383122B (de) 1987-05-25
CA1150287A (en) 1983-07-19
EP0038576B1 (en) 1984-04-11
AU5790380A (en) 1980-11-06
DK153551B (da) 1988-07-25
DK184680A (da) 1980-11-05
EP0038576A3 (en) 1981-11-18
CA1140562A (en) 1983-02-01
GR66729B (no) 1981-04-17
EP0038576A2 (en) 1981-10-28
ES8104996A1 (es) 1981-05-16
ES502179A0 (es) 1982-04-01
ES8203873A1 (es) 1982-04-01
EP0018830A3 (en) 1980-12-10
CA1138469A (en) 1982-12-28
EP0039091B1 (en) 1984-05-30
ES502178A0 (es) 1982-04-01
NO155053B (no) 1986-10-27
DK153551C (da) 1988-12-05
AU534940B2 (en) 1984-02-23

Similar Documents

Publication Publication Date Title
NO155290C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme sulfonylurinstoffderivater.
NO154058C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer.
NO151362C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater.
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO157933C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO144420C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksansyrer
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO151269C (no) Fremgangsmaate for fremstilling av fiskemel
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO151288C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolokinolizindiner
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO152787C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner.
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
NO160203C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fenotiazin-forbindelser.
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO153141C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner.
NO794090L (no) Fremgangsmaate for fremstilling av klordioksyd
NO800251L (no) Fremgangsmaate til fremstilling av beta-laktamforbindelser